Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
JEN Restaurant Group Inc. 3Q 2025 Earnings Call - Navigating Soft Traffic and Aggressive Expansion Amid Inflationary Pressures
JEN Restaurant Group reported a challenging third quarter of 2025 with a 9.9% drop in same-store sales and soft customer traffic exacerbated by external factors like tariffs and the economic crackdown...
- JEN opened 15 new restaurants in first nine months of 2025, exceeding guidance with 17 expected for full year.
- Same-store sales declined 9.9% in Q3 2025 amid macroeconomic pressures and tariff impacts, especially hitting California Hispanic customers.
- Total revenue grew 2.7% year-over-year to $50.4 million, driven by new unit openings despite soft existing store traffic.
- +12 more takeaways
HEI 2025 Q3 Earnings Call - Progress on Wildfire Settlement and Strategic Financial Maneuvers
HEI's Q3 2025 earnings call highlighted steady advancement on several fronts tied tightly to its wildfire litigation and safety strategy. The company is navigating a complex regulatory landscape, movi...
- HEI is progressing its wildfire safety strategy ahead of schedule, fully deploying weather stations and AI-assisted cameras along with hiring its own meteorologist.
- The Maui wildfire tort litigation settlement is advancing toward final court approval, with a hearing scheduled for January 8, 2026, and first payment expected no sooner than early 2026.
- HEI proposed an alternative non-rate case process to rebase rates ahead of the second multi-year PBR period starting January 1, 2027 to save time and costs compared to traditional rate cases.
- +9 more takeaways
American Healthcare REIT Q3 2025 Earnings Call - Strong Organic Growth and Strategic Expansion in Long-Term Care Portfolio
American Healthcare REIT delivered an impressive Q3 2025 with same-store NOI growth of 16.4%, marking its seventh consecutive quarter of double-digit growth. The company’s strategic focus on operating...
- American Healthcare REIT posted 16.4% same-store NOI growth in Q3 2025, sustaining seven consecutive quarters of double-digit growth.
- Occupancy in integrated senior health campuses (Trilogy) and shop segments surpassed 90%, signaling strong demand and pricing power.
- The company closed over $575 million in acquisitions year-to-date, adding two new operator relationships to expand geographic diversification.
- +12 more takeaways
Endeavour Silver Q3 2025 Earnings Call - Terronera Reaches Commercial Production, Driving Growth Amid Cost Challenges
Endeavour Silver delivered a transformative Q3 2025 as Terronera officially entered commercial production, marking a pivotal growth milestone. The company produced 1.8 million oz silver and 7,300 oz g...
- Terronera reached commercial production mid-October after successful commissioning, averaging 90% design capacity and metal recoveries.
- Q3 production was 1.8 million oz silver and 7,300 oz gold excluding Terronera, an 88% increase YoY largely due to Colpa acquisition and Guanacevi’s full quarter.
- Revenue doubled to $111 million from higher precious metal prices and increased output.
- +11 more takeaways
Palomar Holdings Q3 2025 Earnings Call - Robust 44% Premium Growth and Accelerated Earnings Highlight Portfolio Strength and Strategic Acquisition
Palomar Holdings reported an exceptional third quarter in 2025, delivering record gross written premiums up 44% year-over-year and adjusted net income growth of 70%. The company’s diversified specialt...
- Palomar delivered record gross written premium growth of 44% year-over-year in Q3 2025, reflecting diversified strength across all product lines except fronting.
- Adjusted net income grew 70% year-over-year to $55.2 million, representing the 12th consecutive earnings beat and the fourth guidance raise in 2025.
- Adjusted combined ratio improved to 74.8% and adjusted return on equity reached 25.6%, highlighting disciplined underwriting and operational efficiency.
- +10 more takeaways
Goldfields Q3 FY2025 Earnings Call - Reserve Revaluation Bolsters Life Extension Strategy Amid Lease Negotiations
Goldfields reported a solid Q3 FY2025 operational performance with attributable production up 6% quarter-on-quarter and costs trimming 11% on all-in costs, reinforcing confidence in meeting full-year ...
- Q3 FY2025 delivered solid operational performance with 6% production growth quarter-on-quarter and 22% year-on-year increases.
- All-in costs dropped 11% quarter-on-quarter and 4% year-on-year; sustaining costs also declined, aiding margin stability.
- Tarkwa reserves significantly increased from 4.3 million to 7.4 million ounces due to higher reserve price assumptions ($2,000) and removal of operational constraints.
- +10 more takeaways
Silvercorp Q2 Fiscal 2026 Earnings Call - Solid Revenue Growth Masked by Significant Non-Cash Charges
Silvercorp’s Q2 Fiscal 2026 report delivers a mixed bag. Revenue soared 23% year-over-year to $83 million, fueled by higher realized gold and silver prices and a 64% jump in gold sold. However, a cost...
- Revenue rose 23% year-over-year to $83 million, the second highest quarterly revenue achieved.
- Cash flow from operations surged 69% to $39 million thanks to higher realized silver and gold prices.
- Gold sold increased 64% versus the prior year quarter, marking a strong sales performance shift.
- +11 more takeaways
Delek Logistics Partners Q3 2025 Earnings Call - Libby 2 Gas Plant Drives Record EBITDA and Raises Growth Outlook
Delek Logistics Partners delivered a robust third quarter with adjusted EBITDA reaching approximately $136 million, significantly up from $107 million a year earlier. This strong performance, fueled b...
- Delek Logistics reported third-quarter adjusted EBITDA of approximately $136 million, an increase from $107 million the previous year.
- The company raised its full-year EBITDA guidance to between $500 million and $520 million, up from a midpoint of $500 million.
- The recently commissioned Libby 2 gas processing plant is performing as expected, on time and on budget.
- +12 more takeaways
CNH Industrial 2025 Q3 Earnings Call - Navigating Tariffs and Market Uncertainty While Advancing Product Innovation
CNH Industrial's Q3 2025 earnings reveal a challenging global agricultural and construction machinery market, with revenues down 5% quarter-over-quarter and a notable 29% sales drop in North American ...
- CNH’s Q3 2025 revenues declined 5% year-over-year to $4.4 billion, hit by a 29% drop in North American agriculture sales and softened global demand.
- Agricultural dealer inventories continued to reduce, with new inventory levels falling over $200 million sequentially, targeting $1 billion destocking by year-end.
- Tariffs added approximately $140 million in costs in 2025, affecting margins by about 200 basis points in agriculture and 425 basis points in construction.
- +13 more takeaways
IGC Pharma FY 2025 Earnings Call - IGC81 Shows Early Agitation Relief and Potential Disease Modification in Alzheimer's
In its Fiscal Year 2025 shareholder update, IGC Pharma showcased significant advancements around IGC81, its lead Alzheimer's candidate currently in late-phase 2 trials targeting agitation symptoms. Th...
- IGC81 is in a phase 2 trial (Kalma trial) targeting agitation in Alzheimer's dementia, a symptom affecting about 76% of patients worldwide.
- Interim data from first 30 patients show IGC81 reduces agitation significantly by week 2, earlier than existing drug Brexpiprazole that takes about six weeks to act.
- IGC81’s preclinical data indicate potential disease-modifying effects by reducing amyloid plaques and tau tangles, plus improving mitochondrial function in Alzheimer’s mouse models.
- +9 more takeaways